Cite Filings / RNAZ
Feed Companies Filings Check
Sign in

CIK 0001829635 · <br>Emerging growth company

Transcode Therapeutics, Inc.

Sign in to watch
Ticker
RNAZ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811065054
Phone
857-301-6857
Business address
6 LIBERTY SQUARE, #2382, BOSTON, MA, 02109
Filings Insiders Search text
All 324 Financials 111 Shareholder Meetings 16 Executive Compensation 104 Insider Trading 43 Beneficial Ownership Interest 43 Business Combinations 88 Public Offerings 73 Mutual Funds and ETFs 9 Others 47
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-06-02
  3. PRE 14A Proxy Proxy Statement (Preliminary) 2026-05-08
  4. DEF 14A Proxy Proxy Statement 2025-07-15
  5. DEF 14A Proxy Proxy Statement 2025-04-11
  6. PRE 14A Proxy Proxy Statement (Preliminary) 2025-04-02
  7. DEF 14A Proxy Proxy Statement 2024-12-30
  8. PRE 14A Proxy Proxy Statement (Preliminary) 2024-12-19
  9. DEF 14A Proxy Proxy Statement 2024-10-28
  10. PRE 14A Proxy Proxy Statement (Preliminary) 2024-10-15
  11. PRE 14A Proxy Proxy Statement (Preliminary) 2024-05-10
  12. DEF 14A Proxy Proxy Statement 2024-04-29
  13. DEF 14A Proxy Proxy Statement 2023-12-18
  14. PRE 14A Proxy Proxy Statement (Preliminary) 2023-12-08
  15. DEF 14A Proxy Proxy Statement 2023-04-10
  16. PRE 14A Proxy Proxy Statement (Preliminary) 2023-03-31
  17. DEF 14A Proxy Proxy Statement 2022-05-02

Page 1 of 1 · 16 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…